Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Metsera Estimates Value Of Pfizer's Latest Proposal At Between $63.29 And $63.33 Per Share; Novo Nordisk Has Not Subitted New Bid Since Tuesday; Metsera Estimates Novo Nordisk's Latest Bid At Between $69.82 And $70.18 Per Share

Author: Benzinga Newsdesk | November 05, 2025 02:11pm

-Reuters Citing Metsera Letter To Court

Posted In: MTSR NVO PFE